KKR Emerges as Front-Runner to Acquire Healthium Medtech in Big-Bang Deal Valued at $750-850 Million
KKR Emerges as Front-Runner in Bidding War for Healthium Medtech
In a highly competitive bidding process, global private equity firm KKR has positioned itself as the leading contender to acquire Healthium Medtech, formerly known as Sutures India Pvt Ltd, from rival Apax Partners. The deal, estimated to be valued between $750 million to $850 million, is expected to be finalized soon, according to industry sources familiar with the matter.
After Apax Partners expressed interest in selling Healthium Medtech, multiple suitors entered the fray, including a consortium of ChrysCapital & Mankind Pharma and Danish pharma giant Novo Nordisk. However, KKR has emerged as the front-runner in the final stages of the deal, surpassing the other contenders.
Apax Partners had acquired Healthium Medtech in 2018 from investors like TPG Growth and CX Partners, valuing the company at around $350 million at the time. The current proposed valuation reflects the significant growth and potential of the medical devices firm under Apax’s ownership.
Sources close to the deal revealed that KKR’s existing business relationship with Healthium Medtech, including a previous subsidiary sale agreement, has played a crucial role in positioning the firm as the preferred acquirer. An official announcement is expected to follow the final agreement signing.
The sale of Healthium Medtech has generated substantial interest in the market, given the company’s leading position in the surgical sutures category and its global presence. With operations in over 90 countries and a diverse product portfolio, Healthium Medtech has established itself as a key player in the medical devices industry.
As the healthcare sector continues to witness growth and innovation, the acquisition of Healthium Medtech represents a strategic investment opportunity for KKR and other potential buyers. The deal underscores the strong demand for healthcare-related businesses with high growth potential and solid financial performance.
Stay tuned for more updates on this developing story as KKR moves closer to sealing the deal for Healthium Medtech.